1. Home
  2. ABCL vs PRGS Comparison

ABCL vs PRGS Comparison

Compare ABCL & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.97

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Progress Software Corporation (DE)

PRGS

Progress Software Corporation (DE)

HOLD

Current Price

$39.46

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
PRGS
Founded
2012
1981
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
ABCL
PRGS
Price
$5.97
$39.46
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$8.40
$49.50
AVG Volume (30 Days)
7.5M
987.7K
Earning Date
05-11-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
7.79
EPS
N/A
1.03
Revenue
$75,128,000.00
$397,572,000.00
Revenue This Year
N/A
$3.70
Revenue Next Year
$21.85
$1.08
P/E Ratio
N/A
$38.35
Revenue Growth
160.56
N/A
52 Week Low
$2.75
$23.82
52 Week High
$8.44
$51.28

Technical Indicators

Market Signals
Indicator
ABCL
PRGS
Relative Strength Index (RSI) 44.40 63.40
Support Level $5.23 $39.05
Resistance Level $6.79 $44.09
Average True Range (ATR) 0.61 2.08
MACD -0.23 0.09
Stochastic Oscillator 14.66 77.33

Price Performance

Historical Comparison
ABCL
PRGS

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About PRGS Progress Software Corporation (DE)

Progress Software Corp provides software products that enable customers to develop, deploy, and manage AI-powered applications and digital experiences. The Company operates across North America, Latin America, Europe, the Middle East and Africa (EMEA), and Asia Pacific through subsidiaries and distributors, generating a majority of its revenue from the United States. Its product portfolio includes Progress Agentic RAG, Automate MFT, Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, and WhatsUp Gold, offering solutions for application development, data connectivity, DevOps automation, managed file transfer, network security, and digital experience. It generates maximum revenue from the United States.

Share on Social Networks: